Zenas BioPharma, Inc. (ZBIO)
18.40
-0.16
(-0.86%)
USD |
NASDAQ |
May 29, 16:00
18.36
-0.04
(-0.22%)
After-Hours: 20:00
Zenas BioPharma EPS Diluted (Quarterly) : -1.456 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1889 |
| Gilead Sciences, Inc. | 1.612 |
| Nkarta, Inc. | -0.3748 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.99M |
| Total Expenses (Quarterly) | 80.99M |
| Enterprise Value | 796.18M |
| Earnings Yield | -49.44% |
| Normalized Earnings Yield | -35.35 |